VGF4.8 and other similar VGF peptides have been reported in Alzheimer's disease [11,13-15], amyotrophic lateral sclerosis (ALS) [16], and frontotemporal dementia [17]. Here, VGF is linked to amyotrophic lateral sclerosis.